Alzheimer's Disease

Alzheimer's Disease

  • Overview
  • Appointments
  • Symptoms
  • Diagnosis
  • Treatments
  • Patient Resources
  • Locations
  • Doctors

    • What is Alzheimer's Disease?

    Alzheimer’s disease (AD) is a brain disorder that slowly impairs memory and thinking skills. AD is the most common cause of dementia, which leads to a decline in thinking that interferes with one’s everyday functions. An estimated 7 million Americans over the age of 65 have AD, and it is the seventh leading cause of death in the U.S.

    What are the causes of Alzheimer’s disease?

    In most cases, the cause of AD is unknown. In AD, the brain contains abnormal protein deposits called plaques (made up of amyloid protein) and tangles (composed of tau protein). These deposits begin 10-20 years before a person develops symptoms of the disease. In rare cases, AD is caused by a genetic mutation that leads to excess amyloid protein in the brain. Scientists have learned a great deal about what factors may increase a person’s risk of developing AD. 

    The single most important risk factor for developing AD is age. The likelihood of developing AD doubles every 5 years after age 65.

    Additional factors that appear to increase the risk of developing AD include:

    • Family history of AD
    • Other health conditions, such as diabetes and high blood pressure
    • Lack of physical activity
    • Obesity and/or a poor diet
    • Smoking

    Appointment Information

    For more information or to make an appointment, call 734-764-6831.

    What are the symptoms of Alzheimer's Disease?

    AD is often described in stages. Different symptoms mark the different stages of AD, though this varies from person to person. Progression from stage to stage is gradual.

    Early stage

    AD begins gradually and may, at first, be difficult to recognize. Commonly described difficulties include trouble with the following tasks:

    • Remembering recent events
    • Keeping track of time
    • Naming familiar people or things
    • Solving problems
    • Planning
    • Learning new things
         Middle stage

    Memory loss progresses and people find it more difficult to:

    • Read
    • Write
    • Speak
    • Perform household tasks
    • Choose clothing
    • Bathe without reminders
         Late stage

    A person with advanced AD is often unable to:

    • Communicate
    • Recognize people, places, or objects
    • Walk

    They may sleep most of the time and often need full-time care.

         Other symptoms

    Other symptoms that can occur at any stage include changes in:

    • Mood, such as irritability, anxiety, or depression
    • Personality, such as becoming withdrawn or impulsive
    • Behavior, including agitation
    • Thought processes, such as believing things are happening that are not true, or seeing/hearing things that are not there

    How is Alzheimer's Disease diagnosed?

    No single test leads to a diagnosis of AD. Rather a diagnosis is made after a complete evaluation that includes:

    • A detailed history and physical exam, including information from family or others who know the person well
    • Tests to evaluate memory and thinking
    • Blood tests, brain scans, and in some cases genetic tests or spinal fluid testing

    There are now blood tests and brain scans that can detect the changes of Alzheimer’s disease, but it is important for doctors to also look for other conditions that could impair memory and have a different treatment.

    How is Alzheimer's Disease treated?

    There is no known cure for AD. The duration of the disease can vary from a few years to more than 20, though most people live 8-10 years after being diagnosed. There are several prescription drugs used to slow the symptoms and progression of AD:

    Medications (pills or skin patches) that treat the chemical changes that occur in the brain:

    • Donepezil (Aricept®)
    • Galantamine (Razadyne®)
    • Benzgalantamine (Zunveyl®)
    • Rivastigmine (Exelon®)
    • Memantine (Namenda®)
    • A drug containing both donepezil and memantine, called Namzaric®

    Medications (intravenous—given through a vein) that remove the amyloid plaque build-up that occurs in the brain:

    • Lecanemab (Leqembi®)
    • Donanemab (Kisunla®)

    Patient Resources

    More information about AD can be found at:

    Locations
    • Geriatric Neurology Clinic | East Ann Arbor Health & Geriatrics Center 4260 Plymouth Rd
      Level 1
      Ann Arbor, MI 48109-2700       Get Directions

    Doctors

     Search for a U-M Health doctor

    Sami J Barmada, MD, PhD

    Associate Professor

    Neurology

    Judith Lynn Heidebrink, MD

    Judith Lynn Heidebrink, MD

    Clinical Professor

    Neurology

    labcoat

    Steven Gregory MacDonald, MD

    Clinical Assistant Professor

    Neurology

    Henry L Paulson

    Henry Lauris Paulson, MD

    Professor

    Neurology

    Tanav Anand Popli, MD

    Tanav Anand Popli, MD

    Clinical Instructor

    Neurology

    Navid Seraji-Bozorgzad, MD

    Navid Seraji-Bozorgzad, MD

    Clinical Associate Professor

    Neurology, Internal Medicine

    News & Stories
    woman with older woman at table helping on tablet
    Health Lab

    First person-centered measure of dementia caregiving styles improves partner, patient outcomes

    First person-centered measure of dementia caregiving styles improves partner and patient outcomes.
         The Fundamentals Podcast Hero Card Final 1800 x 1350
    The Fundamentals

    The Questions That Shape the Future of Medicine

    On this episode of The Fundamentals, we talked to Dr. Thomas J. Wang, dean of the University of Michigan Medical School, about the fundamental questions that have shaped his career and continue to drive biomedical research. Dean Wang discusses his work in cardiovascular research, the enduring impact of the Framingham Heart Study, the potential of AI and emerging health data, and the importance of collaboration between academia and industry. He also shares advice for the next generation of scientists and physicians and explains why sustained investment in biomedical research is essential to improving human health.
         woman on phone taking notes
    Health Lab

    7 things every family caregiver should know – but many don’t

    A guide to many community resource, and state and federal programs, that University of Michigan polls show caregivers to older adults and people with disabilities often don’t know about.
         couple walking by the water
    Health Lab

    Michigan’s aging brains need more protection, poll shows

    Lifestyle changes can reduce risk of Alzheimer’s disease and other forms of dementia but a poll shows many Michiganders over 50 don’t know about or do them.
         Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
    Health Lab Podcast

    Could preeclampsia become a thing of the past?

    The findings position VGLL3 as a promising novel treatment target for the pregnancy-related condition.
         Minding Memory with a microphone and a shadow of a microphone on a blue background
    Minding Memory

    Addressing Senior Social Isolation in the Community

    In this episode, Matt & Lauren build off their previous conversation with Ashwin Kotwal about social isolation by speaking with Eve Lefkowitz, the Executive Director of the non-profit organization, A Conversation to Remember, which connects older adults – including those who live with cognitive decline – with young adult college students to combat the epidemic of social isolation and loneliness. Lauren & Matt learn about the populations this non-profit serve as well as perspectives on how to address social isolation with older adults.